- Home
- JANX vs LOMA Comparison
JANX vs LOMA Comparison
Compare JANX & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | LOMA |
|---|---|---|
| Founded | 2017 | 1926 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | JANX | LOMA |
|---|---|---|
| Price | $13.61 | $11.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $59.18 | $15.00 |
| AVG Volume (30 Days) | ★ 2.0M | 268.8K |
| Earning Date | 02-26-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $10,000,000.00 | ★ $464,306,268.00 |
| Revenue This Year | N/A | $22.92 |
| Revenue Next Year | N/A | $25.84 |
| P/E Ratio | ★ N/A | $194.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.26 | $7.04 |
| 52 Week High | $47.58 | $14.17 |
Technical Indicators
Market Signals| Indicator | JANX | LOMA |
|---|---|---|
| Relative Strength Index (RSI) | 32.69 | 41.34 |
| Support Level | $13.68 | $11.58 |
| Resistance Level | $14.34 | $12.61 |
| Average True Range (ATR) | 0.46 | 0.50 |
| MACD | 0.43 | -0.17 |
| Stochastic Oscillator | 33.33 | 15.70 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.